Cargando…
Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges
[Image: see text] Central nervous system (CNS) diseases are among the most difficult to treat, mainly because the vast majority of the drugs fail to cross the blood-brain barrier (BBB) or to reach the brain at concentrations adequate to exert a pharmacological activity. The obstacle posed by the BBB...
Autores principales: | Parrasia, Sofia, Szabò, Ildikò, Zoratti, Mario, Biasutto, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644402/ https://www.ncbi.nlm.nih.gov/pubmed/36174227 http://dx.doi.org/10.1021/acs.molpharmaceut.2c00523 |
Ejemplares similares
-
An Angiopep2-PAPTP Construct Overcomes the Blood-Brain Barrier. New Perspectives against Brain Tumors
por: Parrasia, Sofia, et al.
Publicado: (2021) -
Targeting mitochondrial ion channels for cancer therapy
por: Szabo, Ildiko, et al.
Publicado: (2020) -
DA7R: A 7-Letter Zip Code to Target PDAC
por: Parrasia, Sofia, et al.
Publicado: (2023) -
Intracellular ion channels and cancer
por: Leanza, Luigi, et al.
Publicado: (2013) -
Novel Mitochondria-Targeted Furocoumarin Derivatives as Possible Anti-Cancer Agents
por: Mattarei, Andrea, et al.
Publicado: (2018)